Capecitabine
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10158 publications
From metastatic disease to no evidence of disease after conversion liver surgery in advanced gastric cancer with liver metastases: A case report.
Journal: Human vaccines & immunotherapeutics
Published: October 23, 2026
Insights into the degradation behaviour of tucatinib under stress conditions using liquid chromatography high resolution tandem mass spectrometry.
Journal: Analytical methods : advancing methods and applications
Published: October 16, 2026
Nanoparticle-Based Oral Delivery of Capecitabine: In Vitro Cytotoxicity and Pharmacokinetic Evaluation in HepG2 and HT-29 Cell Lines.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: October 15, 2026
Facet-selective molecular regulation of Zn metal anodes for durable aqueous zinc-ion batteries.
Journal: Chemical communications (Cambridge, England)
Published: October 15, 2026
ROLE OF NEOADJUVANT THERAPY FOR PATIENTS WITH GASTRIC CANCER: MULTIDISCIPLINARY HOSPITAL WITH ONCOLOGY CENTER.
Journal: Georgian medical news
Published: October 04, 2026
Radiotherapy dose escalation for the non-operative management of patients with unresectable locally recurrent rectal cancer (STEP-UP): Study protocol for a multicentre, prospective, open-label feasibility study.
Journal: Clinical and translational radiation oncology
Published: September 29, 2026
First-Line Retlirafusp Alfa Plus Chemotherapy for Human Epidermal Growth Factor Receptor 2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Randomized, Double-Blind, Phase III Study (RELIGHT).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 24, 2026
Prognostic factors associated with survival in patients with colorectal cancer treated with capecitabine: A cohort study.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: September 17, 2026
Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.
Journal: Lancet (London, England)
Published: September 16, 2026
Adjuvant chemotherapy with cisplatin and gemcitabine compared to standard of care after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1/AIO-HEP-0112 trial).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 14, 2026
UPP1 as a Diagnostic Biomarker: Insights from Integrative Bioinformatics and Immune Infiltration Analyses in COPD.
Journal: Journal of visualized experiments : JoVE
Published: September 04, 2026
Last Updated: 11/08/2026